| 000 | nam a22 a 4500 | ||
|---|---|---|---|
| 999 |
_c21654 _d21654 |
||
| 001 | BD-DhNSU-21654 | ||
| 003 | BD-DhNSU | ||
| 005 | 20190403064933.0 | ||
| 008 | 190403s2011 ukna|||g |||| 001 0|eng d | ||
| 010 | _a | ||
| 020 | _a9780821387603 | ||
| 040 |
_aDLC _cDLC _dBD-DhNSU |
||
| 041 | _aeng | ||
| 050 | 0 | 0 |
_aRA401 _b.A1R63 2011 |
| 100 | 1 | _aRoberts, Marc J. | |
| 245 | 0 | 0 |
_aPharmaceutical reform : _ba guide to improving performance and equity / _cMarc J. Roberts and Michael R. Reich |
| 260 |
_aWashington, D.C. : _bWorld Bank, _cc2011. |
||
| 300 |
_axx, 332 p. : _bill. ; _c24 cm. |
||
| 650 | 0 | _aPharmaceutical policy | |
| 650 | 4 | _aPharmaceutical industry | |
| 650 | 4 | _aHealth care reform | |
| 700 | 1 | _aReich, Michael R. | |
| 942 |
_2lcc _cBK |
||